
This study investigated whether the prevalence of antinuclear antibodies (ANA), the most common biomarker of autoimmunity, changed over a 25‐year span in the US. The majority of ANA in the US has increased considerably in recent years. Additional studies to determine factors underlying these increases could elucidate causes of autoimmunity and enable the development of preventative measures.
Like
Save
Share